CMB TECH NV (CMBT.BR) Fundamental Analysis & Valuation

EBR:CMBT • BE0003816338

Current stock price

10.6 EUR
-0.48 (-4.33%)
Last:

This CMBT.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CMBT.BR Profitability Analysis

1.1 Basic Checks

  • In the past year CMBT has reported negative net income.
  • In the past year CMBT had a positive cash flow from operations.
  • Of the past 5 years CMBT 4 years were profitable.
  • The reported operating cash flow has been mixed in the past 5 years: CMBT reported negative operating cash flow in multiple years.
CMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFCMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M

1.2 Ratios

  • CMBT has a Return On Assets (3.67%) which is in line with its industry peers.
  • CMBT has a Return On Equity of 12.04%. This is comparable to the rest of the industry: CMBT outperforms 58.02% of its industry peers.
  • CMBT has a Return On Invested Capital of 4.04%. This is in the lower half of the industry: CMBT underperforms 70.37% of its industry peers.
Industry RankSector Rank
ROA 3.67%
ROE 12.04%
ROIC 4.04%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CMBT.BR Yearly ROA, ROE, ROICCMBT.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

  • With a decent Profit Margin value of 17.42%, CMBT is doing good in the industry, outperforming 75.31% of the companies in the same industry.
  • CMBT's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 23.08%, CMBT is in line with its industry, outperforming 59.26% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CMBT has declined.
  • CMBT has a Gross Margin (52.84%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of CMBT has declined.
Industry RankSector Rank
OM 23.08%
PM (TTM) 17.42%
GM 52.84%
OM growth 3Y-1.6%
OM growth 5Y-12.14%
PM growth 3Y-25.83%
PM growth 5Y-24.32%
GM growth 3Y-1.12%
GM growth 5Y-6.04%
CMBT.BR Yearly Profit, Operating, Gross MarginsCMBT.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

0

2. CMBT.BR Health Analysis

2.1 Basic Checks

  • CMBT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • CMBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CMBT.BR Yearly Shares OutstandingCMBT.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT.BR Yearly Total Debt VS Total AssetsCMBT.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 0.86, we must say that CMBT is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of CMBT (0.86) is worse than 80.25% of its industry peers.
  • CMBT has a Debt/Equity ratio of 1.96. This is a high value indicating a heavy dependency on external financing.
  • CMBT has a worse Debt to Equity ratio (1.96) than 91.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Altman-Z 0.86
ROIC/WACC0.6
WACC6.78%
CMBT.BR Yearly LT Debt VS Equity VS FCFCMBT.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

  • A Current Ratio of 0.62 indicates that CMBT may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.62, CMBT is doing worse than 93.83% of the companies in the same industry.
  • A Quick Ratio of 0.51 indicates that CMBT may have some problems paying its short term obligations.
  • CMBT's Quick ratio of 0.51 is on the low side compared to the rest of the industry. CMBT is outperformed by 90.12% of its industry peers.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.51
CMBT.BR Yearly Current Assets VS Current LiabilitesCMBT.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. CMBT.BR Growth Analysis

3.1 Past

  • CMBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -106.08%.
  • CMBT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.73% yearly.
  • The Revenue has grown by 67.96% in the past year. This is a very strong growth!
  • The Revenue has been growing slightly by 6.60% on average over the past years.
EPS 1Y (TTM)-106.08%
EPS 3Y-11.23%
EPS 5Y-20.73%
EPS Q2Q%27.27%
Revenue 1Y (TTM)67.96%
Revenue growth 3Y24.92%
Revenue growth 5Y6.6%
Sales Q2Q%160.64%

3.2 Future

  • The Earnings Per Share is expected to grow by 90.76% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 13.07% on average over the next years. This is quite good.
EPS Next Y650.86%
EPS Next 2Y144.22%
EPS Next 3Y90.76%
EPS Next 5YN/A
Revenue Next Year39.77%
Revenue Next 2Y18.01%
Revenue Next 3Y13.07%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CMBT.BR Yearly Revenue VS EstimatesCMBT.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CMBT.BR Yearly EPS VS EstimatesCMBT.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

4

4. CMBT.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • CMBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • CMBT is valuated reasonably with a Price/Forward Earnings ratio of 9.99.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CMBT indicates a rather cheap valuation: CMBT is cheaper than 85.19% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.54. CMBT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 9.99
CMBT.BR Price Earnings VS Forward Price EarningsCMBT.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CMBT is valued a bit more expensive than the industry average as 76.54% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.42
CMBT.BR Per share dataCMBT.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • CMBT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CMBT's earnings are expected to grow with 90.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y144.22%
EPS Next 3Y90.76%

0

5. CMBT.BR Dividend Analysis

5.1 Amount

  • CMBT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CMBT.BR Fundamentals: All Metrics, Ratios and Statistics

CMB TECH NV

EBR:CMBT (4/10/2026, 7:00:00 PM)

10.6

-0.48 (-4.33%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-26
Earnings (Next)05-19
Inst Owners12.76%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.35B
Revenue(TTM)2.36B
Net Income(TTM)306.64M
Analysts81.54
Price Target13.52 (27.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend4.93
Dividend Growth(5Y)116.35%
DP7.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-173.2%
Min EPS beat(2)-198.04%
Max EPS beat(2)-148.37%
EPS beat(4)0
Avg EPS beat(4)-136.26%
Min EPS beat(4)-198.04%
Max EPS beat(4)-49.61%
EPS beat(8)3
Avg EPS beat(8)39.77%
EPS beat(12)7
Avg EPS beat(12)35.97%
EPS beat(16)10
Avg EPS beat(16)32.67%
Revenue beat(2)2
Avg Revenue beat(2)34.8%
Min Revenue beat(2)22.8%
Max Revenue beat(2)46.8%
Revenue beat(4)3
Avg Revenue beat(4)17.75%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)46.8%
Revenue beat(8)6
Avg Revenue beat(8)22.7%
Revenue beat(12)10
Avg Revenue beat(12)33.52%
Revenue beat(16)14
Avg Revenue beat(16)39.69%
PT rev (1m)12.03%
PT rev (3m)26.28%
EPS NQ rev (1m)-10.2%
EPS NQ rev (3m)7.48%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.04%
Revenue NQ rev (1m)-2.1%
Revenue NQ rev (3m)1.27%
Revenue NY rev (1m)7.18%
Revenue NY rev (3m)5.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.99
P/S 2.22
P/FCF N/A
P/OCF 12.01
P/B 1.54
P/tB 1.66
EV/EBITDA 13.42
EPS(TTM)-0.19
EYN/A
EPS(NY)1.06
Fwd EY10.01%
FCF(TTM)-2.52
FCFYN/A
OCF(TTM)0.88
OCFY8.33%
SpS4.77
BVpS6.9
TBVpS6.38
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.67%
ROE 12.04%
ROCE 5.39%
ROIC 4.04%
ROICexc 4.04%
ROICexgc 4.14%
OM 23.08%
PM (TTM) 17.42%
GM 52.84%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-1.6%
OM growth 5Y-12.14%
PM growth 3Y-25.83%
PM growth 5Y-24.32%
GM growth 3Y-1.12%
GM growth 5Y-6.04%
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Debt/EBITDA 6.9
Cap/Depr 395.78%
Cap/Sales 71.33%
Interest Coverage 1.53
Cash Conversion 45.05%
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.51
Altman-Z 0.86
F-Score3
WACC6.78%
ROIC/WACC0.6
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-106.08%
EPS 3Y-11.23%
EPS 5Y-20.73%
EPS Q2Q%27.27%
EPS Next Y650.86%
EPS Next 2Y144.22%
EPS Next 3Y90.76%
EPS Next 5YN/A
Revenue 1Y (TTM)67.96%
Revenue growth 3Y24.92%
Revenue growth 5Y6.6%
Sales Q2Q%160.64%
Revenue Next Year39.77%
Revenue Next 2Y18.01%
Revenue Next 3Y13.07%
Revenue Next 5YN/A
EBIT growth 1Y-35.16%
EBIT growth 3Y22.92%
EBIT growth 5Y-6.34%
EBIT Next Year146.31%
EBIT Next 3Y31.85%
EBIT Next 5YN/A
FCF growth 1Y-499.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.43%
OCF growth 3YN/A
OCF growth 5YN/A

CMB TECH NV / CMBT.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CMB TECH NV (CMBT.BR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CMBT.BR.


Can you provide the valuation status for CMB TECH NV?

ChartMill assigns a valuation rating of 4 / 10 to CMB TECH NV (CMBT.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for CMB TECH NV?

CMB TECH NV (CMBT.BR) has a profitability rating of 3 / 10.


How financially healthy is CMB TECH NV?

The financial health rating of CMB TECH NV (CMBT.BR) is 0 / 10.


What is the earnings growth outlook for CMB TECH NV?

The Earnings per Share (EPS) of CMB TECH NV (CMBT.BR) is expected to grow by 650.86% in the next year.